| Literature DB >> 24895622 |
Clara Sciorati1, Antonio Esposito2, Lara Campana1, Tamara Canu3, Antonella Monno1, Anna Palmisano3, Francesco De Cobelli2, Alessandro Del Maschio2, Dana P Ascheman4, Angelo A Manfredi5, Patrizia Rovere-Querini5.
Abstract
Inflammatory myopathies comprise heterogeneous disorders. Their etiopathogenesis is poorly understood, because of the paucity of informative experimental models and of approaches for the noninvasive study of inflamed tissues. Magnetic resonance imaging (MRI) provides information about the state of the skeletal muscle that reflects various facets of inflammation and remodeling. This technique has been scarcely used in experimental models of inflammatory myopathies. We characterized the performance of MRI in a well-established mouse model of myositis and the antisynthetase syndrome, based on the immunization of wild-type mice with the amino-terminal fragment of histidyl-tRNA synthetase (HisRS). Over an eight-week period following myositis induction, MRI enabled precise identification of pathological events taking place in muscle tissue. Areas of edema and of active inflammation identified by histopathology paralleled muscle modifications detected noninvasively by MRI. Muscles changes were chronologically associated with the establishment of autoimmunity, as reflected by the development of anti-HisRS antibodies in the blood of immunized mice. MR imaging easily appreciated muscle damage and remodeling even if actual disruption of myofiber integrity (as assessed by serum concentrations of creatinine phosphokinase) was limited. Thus, MR imaging represents an informative and noninvasive analytical tool for studying in vivo immune-mediated muscle involvement.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24895622 PMCID: PMC4026959 DOI: 10.1155/2014/879703
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Experimental settings and timing of evaluations.
| CPK and autoantibodies | MRI | Histopathology | |
|---|---|---|---|
| Autoimmunity | 0, 7, 14, 28, 42, 56 | 0, 7, 14, 28, 42, 56 | 0, 7, 14, 28, 56 |
| Sterile injury | 0, 1, 3, 5, 7, 10, 15, 30 | 0, 1, 3, 5, 10, 30 |
Figure 1Anti-HisRS autoantibody induction is associated with sustained muscle damage. Assessment of anti-HisRS IgG antibodies (a) and CPK activity (b) in serum retrieved before treatment and at various times after immunization. n ≥ 6; *statistically different from sham-treated mice; P < 0.05.
Figure 2T2 MRI mapping reflects inflammation and remodeling in experimental HisRS-induced myositis. Representative T2-weighted images of immunized mice ((a) upper panels) obtained before (time 0) and 14, 28, or 56 days after treatment reveal ongoing inflammatory involvement and are well compatible with results obtained at the same time points by histopathology in selected animals ((a) lower panels, H&E). Yellow arrows indicate the fibula (upper) and tibia (lower) bones, while red arrows show skeletal muscles (GS left and TA right). The graphs show the dynamic trends of T2-rt ((b) y-axis) and F.A. ((d) y-axis) in the longitudinal study of immunized and sham-treated mice before and at various times after treatment (x-axis, days). n ≥ 6; *statistically different from sham-treated mice; P < 0.05. The graph in (c) depicts correlation analysis between T2-rt and the histological score that reflects muscle damage and infiltration (see Methods). n = 3 for each time point. The time points considered for the correlation analysis were days 0, 14, 28, 42, and 56.
Figure 3T2 and DTI MRI mapping reflect independent inflammatory events in acutely injured muscles. Representative T2-weighted images before (time 0) and at various times (1, 5, or 10 days) after intramuscular CTX injection ((a) upper images). Results are compatible with those obtained at the same time points by histopathology in selected animals ((a) lower panels, H&E). The graphs show the dynamic trends of T2-rt ((b) y-axis) and F.A. ((c) y-axis) in the longitudinal study of damaged (CTX) and sham-treated mice before and at various times after treatment (x-axis, days). n ≥ 6; *statistically different from sham-treated mice; P < 0.05.